192 related articles for article (PubMed ID: 37091184)
21. Identification and Validation of Six Autophagy-related Long Non-coding RNAs as Prognostic Signature in Colorectal Cancer.
Cheng L; Han T; Zhang Z; Yi P; Zhang C; Zhang S; Peng W
Int J Med Sci; 2021; 18(1):88-98. PubMed ID: 33390777
[TBL] [Abstract][Full Text] [Related]
22. Explore prognostic marker of colorectal cancer based on ceRNA network.
Ke MJ; Ji LD; Li YX
J Cell Biochem; 2019 Dec; 120(12):19358-19370. PubMed ID: 31490563
[TBL] [Abstract][Full Text] [Related]
23. A network-based predictive gene expression signature for recurrence risks in stage II colorectal cancer.
Yang WJ; Wang HB; Wang WD; Bai PY; Lu HX; Sun CH; Liu ZS; Guan DK; Yang GW; Zhang GL
Cancer Med; 2020 Jan; 9(1):179-193. PubMed ID: 31724326
[TBL] [Abstract][Full Text] [Related]
24. A senescence-based prognostic gene signature for colorectal cancer and identification of the role of SPP1-positive macrophages in tumor senescence.
Yu S; Chen M; Xu L; Mao E; Sun S
Front Immunol; 2023; 14():1175490. PubMed ID: 37090726
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of Nicotinamide N-methyltransferase mainly covers stroma of colorectal cancer and correlates with unfavorable survival by its product 1-MNA.
Yang J; Tong Q; Zhang Y; Yuan S; Gao Y; Deng K; Wang Y; Lu J; Xie X; Zhang Z; Zhang J
J Cancer; 2021; 12(20):6170-6181. PubMed ID: 34539890
[No Abstract] [Full Text] [Related]
26. LINC02595 promotes tumor progression in colorectal cancer by inhibiting miR-203b-3p activity and facilitating BCL2L1 expression.
Yang Z; An Y; Wang N; Dong X; Kang H
J Cell Physiol; 2020 Oct; 235(10):7449-7464. PubMed ID: 32064615
[TBL] [Abstract][Full Text] [Related]
27. Identification of prognostic immune-related gene signature associated with tumor microenvironment of colorectal cancer.
Wang Y; Li W; Jin X; Jiang X; Guo S; Xu F; Su X; Wang G; Zhao Z; Gu X
BMC Cancer; 2021 Aug; 21(1):905. PubMed ID: 34364366
[TBL] [Abstract][Full Text] [Related]
28. Characterization of sialylation-related long noncoding RNAs to develop a novel signature for predicting prognosis, immune landscape, and chemotherapy response in colorectal cancer.
Zhou M; Lv S; Hou Y; Zhang R; Wang W; Yan Z; Li T; Gan W; Zeng Z; Zhang F; Yang M
Front Immunol; 2022; 13():994874. PubMed ID: 36330513
[TBL] [Abstract][Full Text] [Related]
29. Single-cell and WGCNA uncover a prognostic model and potential oncogenes in colorectal cancer.
Di Z; Zhou S; Xu G; Ren L; Li C; Ding Z; Huang K; Liang L; Yuan Y
Biol Proced Online; 2022 Sep; 24(1):13. PubMed ID: 36117173
[TBL] [Abstract][Full Text] [Related]
30. Cancer type classification using plasma cell-free RNAs derived from human and microbes.
Chen S; Jin Y; Wang S; Xing S; Wu Y; Tao Y; Ma Y; Zuo S; Liu X; Hu Y; Chen H; Luo Y; Xia F; Xie C; Yin J; Wang X; Liu Z; Zhang N; Zech Xu Z; Lu ZJ; Wang P
Elife; 2022 Jul; 11():. PubMed ID: 35816095
[TBL] [Abstract][Full Text] [Related]
31. Discovery of a novel six-long non-coding RNA signature predicting survival of colorectal cancer patients.
Fan Q; Liu B
J Cell Biochem; 2018 Apr; 119(4):3574-3585. PubMed ID: 29227531
[TBL] [Abstract][Full Text] [Related]
32. Identification of dysregulated lncRNAs profiling and metastasis-associated lncRNAs in colorectal cancer by genome-wide analysis.
Chen Y; Yu X; Xu Y; Shen H
Cancer Med; 2017 Oct; 6(10):2321-2330. PubMed ID: 28857495
[TBL] [Abstract][Full Text] [Related]
33. RNA sequencing reveals the expression profiles of circRNA and indicates that circDDX17 acts as a tumor suppressor in colorectal cancer.
Li XN; Wang ZJ; Ye CX; Zhao BC; Li ZL; Yang Y
J Exp Clin Cancer Res; 2018 Dec; 37(1):325. PubMed ID: 30591054
[TBL] [Abstract][Full Text] [Related]
34. Integrative Analysis of DNA Methylation and Gene Expression Profiles Identifies Colorectal Cancer-Related Diagnostic Biomarkers.
Xu M; Yuan L; Wang Y; Chen S; Zhang L; Zhang X
Pathol Oncol Res; 2021; 27():1609784. PubMed ID: 34366718
[No Abstract] [Full Text] [Related]
35. CILP2 overexpression correlates with tumor progression and poor prognosis in patients with colorectal cancer in The Cancer Genome Atlas (TCGA) study.
Huang F; Peng Y; Ye Q; Chen J; Li Y; Liu S; Xu Y; Huang L
World J Surg Oncol; 2020 Oct; 18(1):274. PubMed ID: 33099318
[TBL] [Abstract][Full Text] [Related]
36. Comprehensive transcriptome profiling of Taiwanese colorectal cancer implicates an ethnic basis for pathogenesis.
Wu SM; Tsai WS; Chiang SF; Lai YH; Ma CP; Wang JH; Lin J; Lu PS; Yang CY; Tan BC; Liu H
Sci Rep; 2020 Mar; 10(1):4526. PubMed ID: 32161294
[TBL] [Abstract][Full Text] [Related]
37. Transcriptomic profiling of adjuvant colorectal cancer identifies three key prognostic biological processes and a disease specific role for granzyme B.
Daemen A; Udyavar AR; Sandmann T; Li C; Bosch LJW; O'Gorman W; Li Y; Au-Yeung A; Takahashi C; Kabbarah O; Bourgon R; Hegde P; Bais C; Das Thakur M
PLoS One; 2021; 16(12):e0262198. PubMed ID: 34972191
[TBL] [Abstract][Full Text] [Related]
38. N6-Methyladenosine-Related lncRNA Signature Predicts the Overall Survival of Colorectal Cancer Patients.
Song W; Ren J; Yuan W; Xiang R; Ge Y; Fu T
Genes (Basel); 2021 Aug; 12(9):. PubMed ID: 34573357
[TBL] [Abstract][Full Text] [Related]
39. A Robust 6-lncRNA Prognostic Signature for Predicting the Prognosis of Patients With Colorectal Cancer Metastasis.
Li S; Chen S; Wang B; Zhang L; Su Y; Zhang X
Front Med (Lausanne); 2020; 7():56. PubMed ID: 32211413
[No Abstract] [Full Text] [Related]
40. Method for the extraction of circulating nucleic acids based on MOF reveals cell-free RNA signatures in liver cancer.
Sun Y; Yu H; Han S; Ran R; Yang Y; Tang Y; Wang Y; Zhang W; Tang H; Fu B; Fu B; Weng X; Liu SM; Deng H; Peng S; Zhou X
Natl Sci Rev; 2024 Jan; 11(1):nwae022. PubMed ID: 38348130
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]